anonymous
Guest
anonymous
Guest
Anyone in the toxin + filler market should be very worried. Revance has gained a nice size filler market share in two years with minimal effort, not one trade show booth, coupon or TV commercial. Allergan has had years to prepare and did nothing.
Minimal effort? Right.